Alcohol-associated liver disease (ALD) is a major cause of liver transplantation and death worldwide, and its impact is only ...

New peptide drugs could take aim at a broader range of proteins that cause certain cancers, viral infections, and brain ...

VantAI's AI platform will accelerate programmable protein interaction therapies across Halda's cancer and immunology indications.

RNA-binding proteins use a dual binding mechanism involving zinc finger (ZnF) domains and intrinsically disordered regions ...

Membrane protein targeting and insertion is a fundamental process in cellular biology that ensures proteins are correctly delivered to, and integrated within, the lipid bilayer.

Thousands of previously “invisible” microproteins—tiny chains of fewer than 100 amino acids—can profoundly change human ...

The open-source pipeline designs proteins with improved success rates for therapeutic targets, including gene editing proteins and allergens.

Scientists have discovered a new way to advance drug discovery and diagnostics by targeting a part of the proteome (the complete set of proteins in an organism) that was previously thought ...

A Cell Metabolism study reveals that GIPR signaling in oligodendrocytes enhances brain access and weight-loss efficacy of GLP ...

A study published in Nature Biotechnology reveals a powerful new use for artificial intelligence: designing small, drug-like molecules that can stick to and break down harmful proteins in the body - ...